TNBC is a subtype of breast cancer that is deficient in estrogen receptors and progesterone receptors and has low human epidermal growth factor receptor 2 (HER-2) expression, which leads to poor prognosis due to the difficulty of medication in targeted therapy [8,9,10]. This evidence concerns the gene PGR and breast cancer.